tirzepatide lawsuit fda reviews decision to put Lilly's on shortage list Eli Lilly's tirzepatide gained FDA

Bulk Drug Substances That May Not Be Used in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act

The research on creatine for women specifically for muscle preservation, brain function, and recovery has gotten really compelling in the last few years

The official prescribing information for Mounjaro suggests that women using oral contraceptives should switch to a non-oral method or add a barrier method for four weeks after starting the medication and for four weeks after each dose escalation

While it can support energy metabolism, it does not erase the underlying disability, so it is used as part of a broader support strategy [25]

"These GLP-1 agonists can be a two-in-one solution for diabetes and weight loss," Robert Fontana, MD, a Michigan Medicine hepatologist said in an online interview included in the Cure report, "maybe a three-in-one solution if they prove to be safe and effective for metabolic associated steatohepatitis as well." Troubling Pattern in Patient Adherence to GLP-1 Drug Therapy Despite their effectiveness, adhering to the injectable drugs have proven challenging